Evotec SE (ETR:EVT – Get Free Report)’s share price traded down 0.5% on Wednesday . The company traded as low as €8.72 ($9.18) and last traded at €8.81 ($9.27). 1,555,984 shares traded hands during trading, an increase of 14% from the average session volume of 1,360,000 shares. The stock had previously closed at €8.85 ($9.32).
Evotec Stock Performance
The company has a debt-to-equity ratio of 46.81, a quick ratio of 2.97 and a current ratio of 1.83. The company has a market cap of $1.54 billion, a PE ratio of -9.06, a price-to-earnings-growth ratio of 0.98 and a beta of 1.05. The company’s 50 day moving average price is €7.68 and its 200-day moving average price is €7.64.
About Evotec
Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as autoimmune diseases, cancer, CNS diseases, diabetes, fibrosis, immunology, infectious diseases, kidney diseases, liver diseases, pain and inflammation, rare diseases, respiratory diseases, tuberculosis, and women's health.
Featured Articles
- Five stocks we like better than Evotec
- Profitably Trade Stocks at 52-Week Highs
- FinWise Bancorp’s CEO Talks Strategy Behind Fintech Success
- The 3 Best Fintech Stocks to Buy Now
- Broadcom: Turning the Mag 7 Into 8 Trillion-Dollar Tech Giants
- 3 Stocks to Consider Buying in October
- SoundHound AI: Can Its Meteoric Rise Sustain Into 2025?
Receive News & Ratings for Evotec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evotec and related companies with MarketBeat.com's FREE daily email newsletter.
